CHIARITO, MAURO
 Distribuzione geografica
Continente #
NA - Nord America 2.093
AS - Asia 1.586
EU - Europa 661
SA - Sud America 475
AF - Africa 65
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.884
Nazione #
US - Stati Uniti d'America 2.033
SG - Singapore 845
BR - Brasile 414
CN - Cina 408
FI - Finlandia 151
IT - Italia 121
VN - Vietnam 104
IE - Irlanda 94
DE - Germania 84
IN - India 53
SE - Svezia 41
HK - Hong Kong 38
GB - Regno Unito 35
NG - Nigeria 32
AR - Argentina 25
FR - Francia 25
NL - Olanda 22
MX - Messico 21
TR - Turchia 21
CA - Canada 20
BD - Bangladesh 18
IQ - Iraq 15
JP - Giappone 12
PL - Polonia 11
RU - Federazione Russa 11
ES - Italia 10
UA - Ucraina 10
ID - Indonesia 9
MA - Marocco 8
PE - Perù 7
PY - Paraguay 7
TH - Thailandia 7
ZA - Sudafrica 7
BE - Belgio 6
SA - Arabia Saudita 6
TW - Taiwan 6
VE - Venezuela 6
AZ - Azerbaigian 5
CL - Cile 5
KZ - Kazakistan 5
RO - Romania 5
AT - Austria 4
BO - Bolivia 4
CZ - Repubblica Ceca 4
EC - Ecuador 4
KE - Kenya 4
LT - Lituania 4
PK - Pakistan 4
TN - Tunisia 4
CO - Colombia 3
CR - Costa Rica 3
CU - Cuba 3
DZ - Algeria 3
EG - Egitto 3
HN - Honduras 3
IR - Iran 3
JO - Giordania 3
NO - Norvegia 3
OM - Oman 3
RS - Serbia 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AU - Australia 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CH - Svizzera 2
CY - Cipro 2
HR - Croazia 2
IL - Israele 2
JM - Giamaica 2
KG - Kirghizistan 2
PT - Portogallo 2
TT - Trinidad e Tobago 2
UG - Uganda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BB - Barbados 1
BH - Bahrain 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
ML - Mali 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
VG - Isole Vergini Britanniche 1
Totale 4.884
Città #
Singapore 266
The Dalles 241
Shanghai 226
Chandler 193
Dallas 152
Helsinki 150
Ashburn 148
Boardman 111
Wilmington 106
Beijing 102
New York 100
Dublin 93
Los Angeles 57
San Mateo 50
Milan 47
Ho Chi Minh City 39
Pune 37
São Paulo 36
Hong Kong 35
Benin City 32
Munich 26
Hanoi 22
Lawrence 22
Princeton 22
Ann Arbor 20
Seattle 17
Leawood 16
Amsterdam 15
Council Bluffs 13
Fairfield 13
Woodbridge 13
Brooklyn 12
Brasília 11
Curitiba 11
Warsaw 11
Chicago 10
Paris 10
Rio de Janeiro 9
Santa Clara 9
Cologno Monzese 8
Montreal 8
Phoenix 8
Turin 8
Goiânia 7
Kocaeli 7
Mexico City 7
Naples 7
Stockholm 7
Tokyo 7
Boston 6
Brussels 6
Johannesburg 6
Lima 6
Moscow 6
Toronto 6
Abbiategrasso 5
Ankara 5
Baku 5
Campinas 5
Chennai 5
Falkenstein 5
Juiz de Fora 5
Manchester 5
Norwalk 5
Porto Alegre 5
Redmond 5
San Francisco 5
Taipei 5
Assago 4
Belo Horizonte 4
Brescia 4
Denver 4
Haiphong 4
Hải Dương 4
Osasco 4
Salvador 4
Santo André 4
Baghdad 3
Bangkok 3
Basra 3
Biên Hòa 3
Boituva 3
Brno 3
Caxias do Sul 3
Columbus 3
Fazenda Rio Grande 3
Frankfurt am Main 3
Guarulhos 3
Ha Long 3
Havana 3
Istanbul 3
La Paz 3
Lauterbourg 3
London 3
Macapá 3
Monza 3
Muscat 3
Mykolayiv 3
Nova Iguaçu 3
Orem 3
Totale 2.783
Nome #
Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis. 101
Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: Effects on blood pressure control and mortality 96
Coral Reef Aorta: A Rare Occlusive Disease of the Aorta Complicating Decision Making for Severe Aortic Stenosis Treatment. 93
Direct oral anticoagulants in addition to antiplatelet therapy for secondary prevention after acute coronary syndromes: an updated systematic review and meta-analysis 91
Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19 90
Acute coronary syndrome in a patient with a residual aortic dissection flap after supracoronary aortic replacement: the role of intravascular ultrasound 82
Cardioprotection with nebivolol in patients undergoing anthracyclines: a randomized placebo-controlled trial 79
The synergy stent in high-bleeding risk patients: why design matters 70
Impact of Diabetes on Clinical Outcomes After Polymer-Free Amphilimus- and Biolimus-Eluting Stent Implantation 70
Clinical outcomes with reservoir-based polymer-free amphilimus-eluting stents in real-world patients according to diabetes mellitus and complexity: The INVESTIG8 registry. 70
Coronary Revascularisation in Transcatheter Aortic Valve Implantation Candidates: Why, Who, When? Interv Cardiol. 69
Is Transcatheter Aortic Valve Replacement Superior to Surgical Aortic Valve Replacement? A Meta-Analysis of Randomized Controlled Trials. 67
Clinical challenges in an unusual setting: ST-elevation in a patient suffering from graft versus host disease, between thrombosis and coronary spasm 67
Drug-Coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: A meta-analysis of randomized trials 64
Balloon Versus Self-Expandable Valve for the Treatment of Bicuspid Aortic Valve Stenosis: Insights from the BEAT International Collaborative Registrys 64
Impact of High-Density Lipoprotein Levels on Cardiovascular Outcomes of Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents 64
Characterization of Myocardial Injury in Patients With COVID-19 63
Antiplatelet therapy for secondary prevention of cardiovascular disease: challenging the certainties 62
Left atrial appendage closure with the Ultraseal device: Initial experience and mid-term follow-up. 61
Prognostic role of mitral regurgitation in patients with advanced heart failure 61
A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry 60
Safety and efficacy of polymer-free biolimus-eluting stents in all-comer patients: the RUDI-FREE study. 58
Direct oral anticoagulants versus Vitamin K antagonists in the treatment of left ventricular thrombosis: a systematic review and meta-analysis 56
Cardiac and sudden death after chronic total occlusion percutaneous coronary intervention: Prognostic role of the target vessel 55
Safety and efficacy of polymer-free drug-eluting stents: Amphilimus-eluting Cre8 versus biolimus-eluting biofreedom stents 55
Implantation of contemporary transcatheter aortic valves in small aortic annuli: the international multicentre TAVI-SMALL 2 registry 54
A Complicated Case of Resistant Hypertension 54
P2Y12 vs. aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and Meta-analysis 52
Lower dose direct oral anticoagulants and improved survival: A combined analysis in patients with established atherosclerosis 52
Mitral Valve Stenosis after Transcatheter Aortic Valve Replacement: Case Report and Review of the Literature 51
Predicting survival in patients with severe heart failure: risk scores validation in the HELP-HF cohort 50
Impact of complete revascularization on mortality in patients with ST-segment elevation myocardial infarction and multivessel disease: an updated meta-analysis 48
Long-term prognostic impact of subclinical myocardial dysfunction in patients recovered from COVID-19 47
Coronary Revascularisation in Transcatheter Aortic Valve Implantation Candidates: Why, Who, When? 46
[Two-step strategy for the treatment of complex coronary artery disease and aortic stenosis in a patient with severely impaired left ventricular function] 45
Application of the Academic Research Consortium High Bleeding Risk criteria in patients treated with coronary bioresorbable polymer everolimus-eluting stents: Insights from the POEM trial 44
Impact of anemia on short-term outcomes after TAVR: A subgroup analysis from the BRAVO-3 randomized trial 44
Outcome after percutaneous edge-to-edge mitral repair for functional and degenerative mitral regurgitation: a systematic review and meta-analysis 43
Impact of Race/Ethnicity on Long Term Outcomes After Percutaneous Coronary Intervention with Drug-Eluting Stents 42
A sex paradox in clinical outcomes following complex percutaneous coronary intervention 42
Radial versus femoral access for coronary interventions: An updated systematic review and meta-analysis of randomized trials 41
Edge-to-edge percutaneous mitral repair for functional ischaemic and non-ischaemic mitral regurgitation: a systematic review and meta-analysis 41
The Placebo Effect on Symptoms, Quality of Life, and Functional Outcomes in Patients With Angina Pectoris: A Meta-analysis of Randomized Placebo-Controlled Trials 41
Prognostic Value of Baseline Inflammation in Diabetic and Nondiabetic Patients Undergoing Percutaneous Coronary Intervention 40
One-year clinical outcome of amphilimus polymer-free drug-eluting stent in diabetes mellitus patients: Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTre rEgistry) 40
Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with acute coronary syndrome: a meta-analysis 40
GLP-1-ra and heart failure-related outcomes in patients with and without history of heart failure: an updated systematic review and meta-analysis 40
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in patients presenting with acute myocardial infarction: Insight from the ULISSE registry 39
Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey 39
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in diabetic patients: Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 39
Incidence, predictors and clinical impact of permanent pacemaker insertion in women following transcatheter aortic valve implantation: Insights from a prospective multinational registry 38
The Cre8 amphilimus-eluting stent for the treatment of coronary artery disease: safety and efficacy profile 38
Safety and efficacy of an ultra low dose fluoroscopic protocol for chronic total occlusion recanalization 37
Coronary Artery Dissection in Drug-Coated Balloon Angioplasty: Incidence, Predictors, and Clinical Outcomes 37
Impact of target vessel choice on outcomes following percutaneous coronary intervention in patients with a prior coronary artery bypass graft 36
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in all-comers population. Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 36
Impact of Small Valve Size on 1-Year Outcomes After Transcatheter Aortic Valve Implantation in Women (from the WIN-TAVI Registry) 35
Evolution of drug-eluting coronary stents: a back-and-forth journey from the bench-to-bedside 35
Long COVID-19 Cardiac Complications Are Associated With Autoimmunity to Cardiac Self-Antigens Sufficient to Cause Cardiac Dysfunction 35
Reversal and removal of oral antithrombotic drugs in patients with active or perceived imminent bleeding 35
Transcatheter Self-Expandable Valve Implantation for Aortic Stenosis in Small Aortic Annuli The TAVI-SMALL Registry 35
Artificial Intelligence and Cardiovascular Risk Prediction: All That Glitters is not Gold 35
Prognostic value of hypochloremia on mortality in patients with heart failure: a systematic review and meta-analysis 34
Drug-eluting stents in diabetic patients: Are we still treading water? 33
Midterm and one-year outcome of amphilimus polymer free drug eluting stent in patients needing short dual antiplatelet therapy. Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTer rEgistry) 33
Preprocedural anemia in females undergoing transcatheter aortic valve implantation: Insights from the WIN-TAVI registry 33
Polymer-free amphilimus-eluting stent versus biodegradable polymer biolimus-eluting stent in patients with and without diabetes mellitus 33
Treating Inflammation Prior to Percutaneous Coronary Intervention: Does the Heart Care? 33
Periprocedural outcome in patients undergoing left atrial appendage occlusion with the Watchman FLX device: The ITALIAN-FLX registry 32
Risk of cardiac and sudden death with and without revascularisation of a coronary chronic total occlusion 32
Prognostic value of tricuspid regurgitation 32
Ticagrelor Monotherapy After PCI in High-Risk Patients With Prior MI: A Prespecified TWILIGHT Substudy 32
Nebivolol versus placebo in patients undergoing anthracyclines (CONTROL Trial): rationale and study design 32
Silent cerebral injury after transcatheter aortic valve implantation and the preventive role of embolic protection devices: A systematic review and meta-analysis 32
Predictors and Clinical Impact of Prosthesis-Patient Mismatch After Self-Expandable TAVR in Small Annuli 31
Evolving Devices and Material in Transcatheter Aortic Valve Replacement: What to Use and for Whom 31
Characteristics and outcomes of patients with tricuspid regurgitation and advanced heart failure 31
Prevalence and Impact of High Bleeding Risk in Patients Undergoing Left Main Artery Disease PCI 30
Stepwise use of circulatory support devices in a patient refractory to cardiopulmonary resuscitation 30
Low-Dose Colchicine after Myocardial Infarction 29
Perioperative risk and antiplatelet management in patients undergoing non-cardiac surgery within 1 year of PCI 29
SGLT2 inhibitors: a therapy for everybody but not for anything? 29
Frailty according to the 2019 HFA‐ESC definition in patients at risk for advanced heart failure: Insights from the HELP‐HF registry 29
Types of myocardial injury and mid-term outcomes in patients with COVID-19 28
Prognostic impact of the updated 2018 HFA-ESC definition of advanced heart failure: results from the HELP-HF registry 28
The mega COMBO collaboration: An individual patient data pooled analysis of patients undergoing PCI with COMBO stent 28
Postoperative Delirium in Individuals Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis 28
Clinical and prognostic implications of heart failure hospitalization in patients with advanced heart failure 28
Panta rhei, also drug eluting stent technology 27
Perioperative Management of P2Y12 Inhibitors in Patients Undergoing Cardiac Surgery within 1 Year of PCI 27
Efficacy and Safety of P2Y12 Inhibitor Monotherapy After Complex PCI: A Collaborative Systematic Review and Meta-Analysis 27
Two-year cardiac mortality after MitraClip treatment of functional mitral regurgitation in ischemic and non-ischemic dilated cardiomyopathy 27
Safety of metformin continuation in diabetic patients undergoing invasive coronary angiography: the NO-STOP single arm trial 27
Young Patient with Advanced Heart Failure No Longer a Candidate for Heart Transplantation after MitraClip® Procedure 27
Impact of sex on long-term cardiovascular outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromes 26
Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study 26
Clinical burden and predictors of non-cardiovascular mortality and morbidity in advanced heart failure 26
Percutaneous mitral valve repair in acute mitral regurgitation: case report and review of the literature 26
Percutaneous Left Atrial Appendage Closure With the Ultraseal Device: Insights From the Initial Multicenter Experience 26
Single or dual antiplatelet therapy after transcatheter aortic valve implantation. A meta-analysis of randomized controlled trials 26
Totale 4.432
Categoria #
all - tutte 38.491
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.491


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021206 0 0 0 0 0 46 36 12 55 31 0 26
2021/2022137 5 2 5 28 3 1 4 23 11 8 34 13
2022/2023756 54 18 32 96 75 48 16 45 151 106 85 30
2023/2024917 89 84 169 76 34 110 56 58 20 51 78 92
2024/20251.388 32 5 29 23 23 165 84 105 224 346 183 169
2025/20261.559 516 291 213 331 153 55 0 0 0 0 0 0
Totale 4.969